Renaissance BioScience announces project to build proprietary wild yeast discovery platform

Canada | Renaissance BioScience Corp., a global leader in bioengineered yeast that provides solutions for environmental and industrial challenges in the agriculture, food, animal and human health, and energy industries, is pleased to announce a Cad 550,000, 24-month GeneSolve research grant funded by Genome BC and conducted in partnership with Dr. Vivien Measday at the University of British Columbia. The project will build a large, proprietary library of wild yeast strains and aims to accelerate the discovery and commercialization of natural yeast species for a wide variety of high-value industrial applications.

More than 700 natural yeast strains will be characterized in the first phase of this project. Strains with desirable attributes will be selected for advanced genomics analysis, and results will be integrated into a searchable database to enable rapid identification of strains with commercially valuable traits. The project will also generate large genomic and phenotypic datasets that can be leveraged by AI tools to accelerate new strain and technology discovery.

Dr. John Husnik, co-CEO and CSO of Renaissance BioScience, comments: “This project represents a major strategic investment in building a long-term yeast discovery and commercialization platform. By combining our industrial expertise with the Measday Lab’s world-class research infrastructure, we are creating a scalable engine for identifying and validating high-performance yeast strains that can have important industrial applications and drive multiple future revenue streams.”

Through the partnership with Dr. Measday, the company gains access to specialized robotic screening systems, sequencing coordination, and advanced analytical infrastructure for bioprospecting high-value yeast strains.

The project’s initial commercial focus is on identifying yeast strains capable of valorising waste substrates, thereby transforming low-value byproducts and waste streams into high-value industrial compounds. Using high-throughput screening, the team will rapidly evaluate large numbers of strains to identify those best suited to specific waste streams. The most promising candidates will be advanced based on their ability to convert these materials into value-added molecules such as enzymes, biosurfactants, emulsifiers, and nutraceuticals. These products have applications across food, specialized nutrition, agriculture, energy, and broader industrial markets.

The bioprospecting initiative has already generated strong interest from potential commercial partners and academic collaborators, reflecting growing market recognition of the platform’s strategic value.